Clinical Trials Logo

Emergency Contraception clinical trials

View clinical trials related to Emergency Contraception.

Filter by:

NCT ID: NCT01569113 Completed - Clinical trials for Emergency Contraception

Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.

Start date: March 2012
Phase: Phase 4
Study type: Interventional

The purposes of this study are to compare the effects on ovarian activity of quick starting a Combined Oral Contraceptive Pill (COCP) after ellaOne® or placebo intake.

NCT ID: NCT00777556 Completed - Clinical trials for Emergency Contraception

Emergency Contraception Actual Use Study

Start date: October 2008
Phase: Phase 3
Study type: Interventional

This is a non-comparative case series study to assess the ability of females 11-16 years of age, inclusive, who are requesting emergency contraception (EC) to use the study product, DR-104 (Plan B® 1.5), appropriately and safely without provider counseling.

NCT ID: NCT00677755 Completed - Abortion, Induced Clinical Trials

Medical Abortion for Emergency Contraception Failure

Start date: October 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the efficacy, safety and acceptability of pre-treatment with mifepristone and misoprostol compared to misoprostol alone in the medical termination of pregnancy by mifepristone EC failure.

NCT ID: NCT00411684 Completed - Clinical trials for Emergency Contraception

Safety and Efficacy of CDB-2914 for Emergency Contraception

Start date: November 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.

NCT ID: NCT00271583 Completed - Clinical trials for Emergency Contraception

Efficacy Trial of CDB 2914 for Emergency Contraception

Start date: September 1999
Phase: Phase 2/Phase 3
Study type: Interventional

Objective: To compare the efficacy, safety and tolerance of a 50 mg dose of a new antiprogestin, CDB-2914 with a 0.75 mg bid dose of levonorgestrel as emergency contraception Design: Multicenter, randomized, double blind Phase II study to compare a 50 mg dose of CDB-2914 to a 0.75 mg bid dose of levonorgestrel as emergency contraception Subjects are randomized to receive a one-time treatment with either one dose of 50 mg CDB-2914 (followed 12 hours later by a placebo) or 2 doses of 0.75 mg of levonorgestrel with follow-up visits at 5-7 days after expected onset of menses and another visit at 12-14 days after expected onset of menses (if needed) The primary aim is to evaluate the efficacy of CDB-2914 used by subjects as an emergency postcoital contraceptive in comparison to a group of subjects receiving levonorgestrel.